Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 2624 studies with search of: | "breast cancer" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Active, not recruiting |
Capecitabine in Women With Operable Breast Cancer
|
||||
2 | Completed |
A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer
|
||||
3 | Not yet recruiting |
Efficacy and Safety Study Evaluating IPI-504 With Trastuzumab in Patients With Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer
|
||||
4 | Recruiting |
Study to Evaluate Exemestane With and Without SNDX-275 in Treatment of Postmenopausal Women With Advanced Breast Cancer
|
||||
5 | Active, not recruiting |
Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer
|
||||
6 | Not yet recruiting |
Safety Study of AMG 386 to Treat HER2-Positive Locally Recurrent or Metastatic Breast Cancer
|
||||
7 | Recruiting |
MPA Revisited: A Phase II Study of Anti-Metastatic, Anti-Angiogenic Therapy in Postmenopausal Patients With Hormone Receptor Negative Breast Cancer. A Translational Breast Cancer Research Consortium (TBCRC) Trial
|
||||
8 | Active, not recruiting |
A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer
|
||||
9 | Active, not recruiting |
Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast Cancer
|
||||
10 | Active, not recruiting |
Preoperative Herceptin and Navelbine for Breast Cancer
|
||||
11 | Withdrawn |
Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer
|
||||
12 | Recruiting |
Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-Line Therapy in HER2/Neu-Positive Breast Cancer
|
||||
13 | Terminated |
DOXIL® vs. Xeloda® as First Line Chemotherapy for Metastatic Breast Cancer in Women 60 Years and Older
|
||||
14 | Active, not recruiting |
Phase I/ II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer
|
||||
15 | Completed |
Study of Larotaxel in Combination With Weekly Herceptin® in Patients With HER2 Positive Metastatic Breast Cancer
|
||||
16 | Recruiting |
Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer
|
||||
17 | Recruiting |
Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer
|
||||
18 | Active, not recruiting |
A Trial of Taxol and Bevacizumab vs. Gemcitabine, Taxol, and Bevacizumab in Advanced Breast Cancer
|
||||
19 | Completed |
Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy
|
||||
20 | Active, not recruiting |
Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer
|
Previous Page | Studies Shown (1-20) | Next (21-40) |